Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2012 1
2013 1
2014 1
2016 1
2018 1
2019 6
2020 4
2021 5
2022 7
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Nakagawa K, Garon EB, Seto T, Nishio M, Ponce Aix S, Paz-Ares L, Chiu CH, Park K, Novello S, Nadal E, Imamura F, Yoh K, Shih JY, Au KH, Moro-Sibilot D, Enatsu S, Zimmermann A, Frimodt-Moller B, Visseren-Grul C, Reck M; RELAY Study Investigators. Nakagawa K, et al. Among authors: au kh. Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4. Lancet Oncol. 2019. PMID: 31591063 Clinical Trial.
Virtual Contrast-Enhanced Magnetic Resonance Images Synthesis for Patients With Nasopharyngeal Carcinoma Using Multimodality-Guided Synergistic Neural Network.
Li W, Xiao H, Li T, Ren G, Lam S, Teng X, Liu C, Zhang J, Kar-Ho Lee F, Au KH, Ho-Fun Lee V, Chang ATY, Cai J. Li W, et al. Among authors: au kh. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):1033-1044. doi: 10.1016/j.ijrobp.2021.11.007. Epub 2021 Nov 12. Int J Radiat Oncol Biol Phys. 2022. PMID: 34774997
Multi-Organ Omics-Based Prediction for Adaptive Radiation Therapy Eligibility in Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy.
Lam SK, Zhang Y, Zhang J, Li B, Sun JC, Liu CY, Chou PH, Teng X, Ma ZR, Ni RY, Zhou T, Peng T, Xiao HN, Li T, Ren G, Cheung AL, Lee FK, Yip CW, Au KH, Lee VH, Chang AT, Chan LW, Cai J. Lam SK, et al. Among authors: au kh. Front Oncol. 2022 Jan 31;11:792024. doi: 10.3389/fonc.2021.792024. eCollection 2021. Front Oncol. 2022. PMID: 35174068 Free PMC article.
27 results